Copyright
©The Author(s) 2025.
World J Gastrointest Oncol. Jul 15, 2025; 17(7): 107971
Published online Jul 15, 2025. doi: 10.4251/wjgo.v17.i7.107971
Published online Jul 15, 2025. doi: 10.4251/wjgo.v17.i7.107971
Figure 7 In vivo, SAC3 domain containing 1 significantly promotes the progression of hepatocellular carcinoma.
aP < 0.05, bP < 0.01, cP < 0.001. A: Xenograft tumor of MHCC-97H SAC3 domain containing 1 overexpression and MHCC-97H control (Ctrl) cells and hematoxylin and eosin staining, bar = 50 μm; B: Statistical analysis of xenograft tumor volume and tumor weight; C and D: Immunohistochemistry detection and statistical analysis of the expression and positive rates of SAC3 domain containing 1, β-Catenin, c-Myc, glucose transporter 1, hexokinase 2, pyruvate kinase M2 and lactate dehydrogenase A, bar = 50 μm. OE: Over expression; NS: No significance; SAC3D1: SAC3 domain containing 1;GLUT1: Glucose transporter 1; HK2: Hexokinase 2; PKM2: Pyruvate kinase M2; LDHA: Lactate dehydrogenase A.
- Citation: Lin XJ, Tang EJ, Sun B, Wang AL, Chen Y, Chen L, Xue YY, Li AJ, Liu CY. SAC3 domain containing 1 intervention in energy metabolism reprogramming assists in the progression of hepatocellular carcinoma. World J Gastrointest Oncol 2025; 17(7): 107971
- URL: https://www.wjgnet.com/1948-5204/full/v17/i7/107971.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i7.107971